|

Exparel Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: bupivacaine liposome injectable suspension

Pipeline

Phase 1: 1Phase 3: 1Phase 4: 1

Top Sponsors

  • Wake Forest University Health Sciences1
  • University of Cincinnati1
  • Pacira Pharmaceuticals, Inc1

Indications

  • Cancer2
  • Nephrectomy / Methods1
  • Heart Disease1
  • Mastectomy; Lymphedema1
  • Pain Management1

Indianapolis, Indiana1 trial

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Indiana University Health, Riley Hospital For Children

Phase 1

Charlotte, North Carolina1 trial

R.E.C.K vs Exparel in Robotic Nephrectomy

Levine Cancer

Phase 3

Cincinnati, Ohio1 trial

Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks

University of Cincinnati Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.